LAVA Therapeutics NV (LVTX) Company Profile & Statistics

LAVA Therapeutics NV
LVTX
(Nasdaq - US)
Open
1.54
+0.06 (+4.05%)
in:usd•As of: Nov 22, 2024 10:13 UTC -5
Open
1.54
High
1.54
Low
1.54

About LAVA Therapeutics NV

CEO

Stephen Hurly

Headquarters

yalelaan 62

utrecht, p7 3584 cm, netherlands

Auditor

PricewaterhouseCoopers Accountants N.V.

Employees

Share Holders

N/A

Website

www.lavatherapeutics.com

Industry

biotechnology

Sector

health technology

Company Overview

LAVA Therapeutics B.V. is a biotechnology company. It focuses on applying its expertise in bispecific gamma-delta T cell engagers to transform cancer therapy. LAVA Therapeutics B.V. is based in UTRECHT, The Netherlands.

LAVA Therapeutics NV Statistics

Valuation Measures

Market Capitalization ²	N/A
Enterprise Value	N/A
Enterprise Value/EBITDA (ttm)	N/A
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	0.46
Price to Sales (ttm)	N/A
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	59.38%
Operating Margin (ttm)	-228.02%
Profit Margin (ttm)	-4630.10%
Return on Equity (ttm)	-48.53%
Return on Invested Capital (ttm)	-48.84%
Return on Assets (ttm)	-23.94%

Income Statement

Revenue (ttm)	7.40M
Revenue Per Share (ttm)	N/A
Gross Profit (ttm)	7.23M
EBITDA (ttm)³	-28.69M
Net Income Avi to Common (ttm)	-24.18M
Diluted EPS (ttm)	-0.91

Share Statistics

Beta (5Y Monthly)	0.49
52-Week Change	2.67%
S&P500 52-Week Change	30.68%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	N/A
Dividend Yield	0.00%
Float ⁴	0.00
% Held by Insiders	0.79%
% Held by Institutions	0.00%

Balance Sheet

Total Cash (mrq)	86.80M
Total Cash Per Share (mrq)	N/A
Total Debt (mrq)	6.16M
Total Debt/Equity (mrq)	14.37%
Current Ratio (mrq)	6.39%
Quick Ratio (mrq)	6.39%
Book Value Per Share (mrq)	1.63

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.35
Free Cash Flow (ytd)	-9.42M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

LAVA Therapeutics NV

Trade With A Regulated Broker